HEADER CEPHALOSPORINASE 04-JUN-98 3BLS TITLE AMPC BETA-LACTAMASE FROM ESCHERICHIA COLI COMPND MOL_ID: 1; COMPND 2 MOLECULE: AMPC BETA-LACTAMASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.5.2.6; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 83333; SOURCE 4 STRAIN: K12; SOURCE 5 CELLULAR_LOCATION: PERIPLASM; SOURCE 6 GENE: AMPC; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: JM109; SOURCE 10 EXPRESSION_SYSTEM_CELLULAR_LOCATION: EXTRACELLULAR; SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: POG0295; SOURCE 13 EXPRESSION_SYSTEM_GENE: AMPC KEYWDS CEPHALOSPORINASE, BETA-LACTAMASE, SERINE HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR K.C.USHER,B.K.SHOICHET,S.J.REMINGTON REVDAT 4 09-AUG-23 3BLS 1 REMARK LINK REVDAT 3 13-JUL-11 3BLS 1 VERSN REVDAT 2 24-FEB-09 3BLS 1 VERSN REVDAT 1 12-AUG-98 3BLS 0 JRNL AUTH K.C.USHER,L.C.BLASZCZAK,G.S.WESTON,B.K.SHOICHET, JRNL AUTH 2 S.J.REMINGTON JRNL TITL THREE-DIMENSIONAL STRUCTURE OF AMPC BETA-LACTAMASE FROM JRNL TITL 2 ESCHERICHIA COLI BOUND TO A TRANSITION-STATE ANALOGUE: JRNL TITL 3 POSSIBLE IMPLICATIONS FOR THE OXYANION HYPOTHESIS AND FOR JRNL TITL 4 INHIBITOR DESIGN. JRNL REF BIOCHEMISTRY V. 37 16082 1998 JRNL REFN ISSN 0006-2960 JRNL PMID 9819201 JRNL DOI 10.1021/BI981210F REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 3 NUMBER OF REFLECTIONS : 35707 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.159 REMARK 3 R VALUE (WORKING SET) : 0.159 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 0 REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2160 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2160 REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 0.00 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 0 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 35707 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5580 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 20 REMARK 3 SOLVENT ATOMS : 107 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : 18.600 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.019 ; 1.000 ; 5762 REMARK 3 BOND ANGLES (DEGREES) : 2.690 ; 2.000 ; 7824 REMARK 3 TORSION ANGLES (DEGREES) : 18.400; 0.000 ; 3308 REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : 0.013 ; 2.000 ; 138 REMARK 3 GENERAL PLANES (A) : 0.019 ; 5.000 ; 820 REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : 8.010 ; 0.500 ; 5768 REMARK 3 NON-BONDED CONTACTS (A) : 0.023 ; 20.000; 101 REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : BABINET SCALING REMARK 3 KSOL : 0.99 REMARK 3 BSOL : 531.0 REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : TNT PROTGEO REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : TNT BCORREL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3BLS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000178892. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NOV-95 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 8.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH2R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE(002) REMARK 200 OPTICS : COLLIMATOR REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : XUONG-HAMLIN MULTIWIRE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : UCSD REMARK 200 DATA SCALING SOFTWARE : UCSD REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35225 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.08800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.48 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.21600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR SUBSTITUTION REMARK 200 SOFTWARE USED: TNT REMARK 200 STARTING MODEL: PDB ENTRY 2BLS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN WAS CRYSTALLIZED FROM 1.7M REMARK 280 NA/K PHOSPHATE, PH 8.7, COCRYSTALLIZED IN THE PRESENCE OF MAPB REMARK 280 INHIBITOR. LARGER CRYSTALS WERE GROWN BY MICRO-SEEDING TECHNIQUE. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 59.69000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.48500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 59.69000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 39.48500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 361 REMARK 465 GLN B 361 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 99 CG CD CE NZ REMARK 480 LYS A 126 CG CD CE NZ REMARK 480 LYS A 246 CG CD CE NZ REMARK 480 LYS A 290 CG CD CE NZ REMARK 480 LYS B 99 CD CE NZ REMARK 480 LYS B 126 CD CE NZ REMARK 480 ASN B 244 CG OD1 ND2 REMARK 480 LYS B 246 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 171 CD GLU A 171 OE2 0.069 REMARK 500 GLU A 196 CD GLU A 196 OE2 0.073 REMARK 500 GLU A 205 CD GLU A 205 OE1 0.067 REMARK 500 GLU A 245 CD GLU A 245 OE2 0.067 REMARK 500 GLU A 331 CD GLU A 331 OE1 0.080 REMARK 500 GLU A 333 CD GLU A 333 OE1 0.068 REMARK 500 GLU B 21 CD GLU B 21 OE1 0.089 REMARK 500 GLU B 95 CD GLU B 95 OE2 0.073 REMARK 500 GLU B 171 CD GLU B 171 OE2 0.087 REMARK 500 GLU B 196 CD GLU B 196 OE2 0.078 REMARK 500 GLU B 205 CD GLU B 205 OE1 0.080 REMARK 500 GLU B 245 CD GLU B 245 OE2 0.068 REMARK 500 GLU B 331 CD GLU B 331 OE1 0.084 REMARK 500 GLU B 333 CD GLU B 333 OE1 0.069 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ALA A 29 N - CA - CB ANGL. DEV. = 8.8 DEGREES REMARK 500 ASP A 47 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 ASP A 87 CB - CG - OD2 ANGL. DEV. = 5.4 DEGREES REMARK 500 PRO A 94 C - N - CD ANGL. DEV. = -15.7 DEGREES REMARK 500 ASP A 130 CB - CG - OD2 ANGL. DEV. = 5.4 DEGREES REMARK 500 ARG A 177 NE - CZ - NH1 ANGL. DEV. = 3.9 DEGREES REMARK 500 ASP A 217 CB - CG - OD1 ANGL. DEV. = 6.4 DEGREES REMARK 500 ASP A 242 CB - CG - OD1 ANGL. DEV. = 5.7 DEGREES REMARK 500 ASP A 242 CB - CG - OD2 ANGL. DEV. = -6.4 DEGREES REMARK 500 ARG A 258 NE - CZ - NH1 ANGL. DEV. = -3.6 DEGREES REMARK 500 ASP A 264 CB - CG - OD2 ANGL. DEV. = -7.5 DEGREES REMARK 500 ASP A 275 CB - CG - OD1 ANGL. DEV. = -7.5 DEGREES REMARK 500 ASP A 281 CB - CG - OD1 ANGL. DEV. = -5.8 DEGREES REMARK 500 ASP A 288 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 ARG A 296 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 LEU A 334 CB - CA - C ANGL. DEV. = -12.1 DEGREES REMARK 500 GLN B 56 CA - CB - CG ANGL. DEV. = -15.6 DEGREES REMARK 500 ASP B 76 CB - CG - OD2 ANGL. DEV. = -7.9 DEGREES REMARK 500 THR B 97 N - CA - CB ANGL. DEV. = -11.6 DEGREES REMARK 500 ASP B 123 CB - CG - OD1 ANGL. DEV. = -5.7 DEGREES REMARK 500 ARG B 133 NE - CZ - NH1 ANGL. DEV. = 3.9 DEGREES REMARK 500 ARG B 148 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG B 177 NE - CZ - NH1 ANGL. DEV. = 5.0 DEGREES REMARK 500 ARG B 177 NE - CZ - NH2 ANGL. DEV. = -3.7 DEGREES REMARK 500 TYR B 199 CB - CG - CD2 ANGL. DEV. = -5.7 DEGREES REMARK 500 TYR B 199 CB - CG - CD1 ANGL. DEV. = 5.2 DEGREES REMARK 500 ASP B 217 CB - CG - OD1 ANGL. DEV. = 7.3 DEGREES REMARK 500 LYS B 224 N - CA - CB ANGL. DEV. = 11.4 DEGREES REMARK 500 ASP B 264 CB - CG - OD2 ANGL. DEV. = -8.1 DEGREES REMARK 500 ASP B 281 CB - CG - OD1 ANGL. DEV. = -5.8 DEGREES REMARK 500 ARG B 296 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 THR B 319 CA - CB - CG2 ANGL. DEV. = -12.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 7 -70.27 -39.62 REMARK 500 ASN A 102 -77.52 -37.39 REMARK 500 LYS A 126 -70.54 -117.50 REMARK 500 TYR A 150 109.00 -42.28 REMARK 500 VAL A 178 -62.57 -120.80 REMARK 500 LYS A 183 33.11 73.79 REMARK 500 GLU A 205 33.62 70.46 REMARK 500 TYR A 221 20.52 -153.79 REMARK 500 ASN A 341 50.06 -91.62 REMARK 500 ALA A 359 7.53 -67.14 REMARK 500 LYS B 24 42.17 73.70 REMARK 500 ASN B 102 -83.00 -27.48 REMARK 500 VAL B 178 -60.33 -123.31 REMARK 500 GLN B 180 -70.90 -49.39 REMARK 500 LEU B 216 12.38 55.58 REMARK 500 TYR B 221 24.18 -159.95 REMARK 500 ALA B 307 109.57 -41.90 REMARK 500 LYS B 315 133.66 -171.35 REMARK 500 ASN B 341 40.94 -91.08 REMARK 500 PRO B 345 128.76 -37.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: ACT REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: ENZYME ACTIVE SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: ACB REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: ENZYME ACTIVE SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE APB A 362 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE APB B 362 DBREF 3BLS A 4 361 UNP P00811 AMPC_ECOLI 20 377 DBREF 3BLS B 4 361 UNP P00811 AMPC_ECOLI 20 377 SEQRES 1 A 358 ALA PRO GLN GLN ILE ASN ASP ILE VAL HIS ARG THR ILE SEQRES 2 A 358 THR PRO LEU ILE GLU GLN GLN LYS ILE PRO GLY MET ALA SEQRES 3 A 358 VAL ALA VAL ILE TYR GLN GLY LYS PRO TYR TYR PHE THR SEQRES 4 A 358 TRP GLY TYR ALA ASP ILE ALA LYS LYS GLN PRO VAL THR SEQRES 5 A 358 GLN GLN THR LEU PHE GLU LEU GLY SER VAL SER LYS THR SEQRES 6 A 358 PHE THR GLY VAL LEU GLY GLY ASP ALA ILE ALA ARG GLY SEQRES 7 A 358 GLU ILE LYS LEU SER ASP PRO THR THR LYS TYR TRP PRO SEQRES 8 A 358 GLU LEU THR ALA LYS GLN TRP ASN GLY ILE THR LEU LEU SEQRES 9 A 358 HIS LEU ALA THR TYR THR ALA GLY GLY LEU PRO LEU GLN SEQRES 10 A 358 VAL PRO ASP GLU VAL LYS SER SER SER ASP LEU LEU ARG SEQRES 11 A 358 PHE TYR GLN ASN TRP GLN PRO ALA TRP ALA PRO GLY THR SEQRES 12 A 358 GLN ARG LEU TYR ALA ASN SER SER ILE GLY LEU PHE GLY SEQRES 13 A 358 ALA LEU ALA VAL LYS PRO SER GLY LEU SER PHE GLU GLN SEQRES 14 A 358 ALA MET GLN THR ARG VAL PHE GLN PRO LEU LYS LEU ASN SEQRES 15 A 358 HIS THR TRP ILE ASN VAL PRO PRO ALA GLU GLU LYS ASN SEQRES 16 A 358 TYR ALA TRP GLY TYR ARG GLU GLY LYS ALA VAL HIS VAL SEQRES 17 A 358 SER PRO GLY ALA LEU ASP ALA GLU ALA TYR GLY VAL LYS SEQRES 18 A 358 SER THR ILE GLU ASP MET ALA ARG TRP VAL GLN SER ASN SEQRES 19 A 358 LEU LYS PRO LEU ASP ILE ASN GLU LYS THR LEU GLN GLN SEQRES 20 A 358 GLY ILE GLN LEU ALA GLN SER ARG TYR TRP GLN THR GLY SEQRES 21 A 358 ASP MET TYR GLN GLY LEU GLY TRP GLU MET LEU ASP TRP SEQRES 22 A 358 PRO VAL ASN PRO ASP SER ILE ILE ASN GLY SER ASP ASN SEQRES 23 A 358 LYS ILE ALA LEU ALA ALA ARG PRO VAL LYS ALA ILE THR SEQRES 24 A 358 PRO PRO THR PRO ALA VAL ARG ALA SER TRP VAL HIS LYS SEQRES 25 A 358 THR GLY ALA THR GLY GLY PHE GLY SER TYR VAL ALA PHE SEQRES 26 A 358 ILE PRO GLU LYS GLU LEU GLY ILE VAL MET LEU ALA ASN SEQRES 27 A 358 LYS ASN TYR PRO ASN PRO ALA ARG VAL ASP ALA ALA TRP SEQRES 28 A 358 GLN ILE LEU ASN ALA LEU GLN SEQRES 1 B 358 ALA PRO GLN GLN ILE ASN ASP ILE VAL HIS ARG THR ILE SEQRES 2 B 358 THR PRO LEU ILE GLU GLN GLN LYS ILE PRO GLY MET ALA SEQRES 3 B 358 VAL ALA VAL ILE TYR GLN GLY LYS PRO TYR TYR PHE THR SEQRES 4 B 358 TRP GLY TYR ALA ASP ILE ALA LYS LYS GLN PRO VAL THR SEQRES 5 B 358 GLN GLN THR LEU PHE GLU LEU GLY SER VAL SER LYS THR SEQRES 6 B 358 PHE THR GLY VAL LEU GLY GLY ASP ALA ILE ALA ARG GLY SEQRES 7 B 358 GLU ILE LYS LEU SER ASP PRO THR THR LYS TYR TRP PRO SEQRES 8 B 358 GLU LEU THR ALA LYS GLN TRP ASN GLY ILE THR LEU LEU SEQRES 9 B 358 HIS LEU ALA THR TYR THR ALA GLY GLY LEU PRO LEU GLN SEQRES 10 B 358 VAL PRO ASP GLU VAL LYS SER SER SER ASP LEU LEU ARG SEQRES 11 B 358 PHE TYR GLN ASN TRP GLN PRO ALA TRP ALA PRO GLY THR SEQRES 12 B 358 GLN ARG LEU TYR ALA ASN SER SER ILE GLY LEU PHE GLY SEQRES 13 B 358 ALA LEU ALA VAL LYS PRO SER GLY LEU SER PHE GLU GLN SEQRES 14 B 358 ALA MET GLN THR ARG VAL PHE GLN PRO LEU LYS LEU ASN SEQRES 15 B 358 HIS THR TRP ILE ASN VAL PRO PRO ALA GLU GLU LYS ASN SEQRES 16 B 358 TYR ALA TRP GLY TYR ARG GLU GLY LYS ALA VAL HIS VAL SEQRES 17 B 358 SER PRO GLY ALA LEU ASP ALA GLU ALA TYR GLY VAL LYS SEQRES 18 B 358 SER THR ILE GLU ASP MET ALA ARG TRP VAL GLN SER ASN SEQRES 19 B 358 LEU LYS PRO LEU ASP ILE ASN GLU LYS THR LEU GLN GLN SEQRES 20 B 358 GLY ILE GLN LEU ALA GLN SER ARG TYR TRP GLN THR GLY SEQRES 21 B 358 ASP MET TYR GLN GLY LEU GLY TRP GLU MET LEU ASP TRP SEQRES 22 B 358 PRO VAL ASN PRO ASP SER ILE ILE ASN GLY SER ASP ASN SEQRES 23 B 358 LYS ILE ALA LEU ALA ALA ARG PRO VAL LYS ALA ILE THR SEQRES 24 B 358 PRO PRO THR PRO ALA VAL ARG ALA SER TRP VAL HIS LYS SEQRES 25 B 358 THR GLY ALA THR GLY GLY PHE GLY SER TYR VAL ALA PHE SEQRES 26 B 358 ILE PRO GLU LYS GLU LEU GLY ILE VAL MET LEU ALA ASN SEQRES 27 B 358 LYS ASN TYR PRO ASN PRO ALA ARG VAL ASP ALA ALA TRP SEQRES 28 B 358 GLN ILE LEU ASN ALA LEU GLN HET APB A 362 10 HET APB B 362 10 HETNAM APB M-AMINOPHENYLBORONIC ACID FORMUL 3 APB 2(C6 H8 B N O2) FORMUL 5 HOH *107(H2 O) HELIX 1 1 GLN A 6 GLN A 23 1 18 HELIX 2 2 GLY A 63 ALA A 79 5 17 HELIX 3 3 THR A 89 LYS A 91 5 3 HELIX 4 4 LYS A 99 TRP A 101 5 3 HELIX 5 5 LEU A 106 ALA A 110 1 5 HELIX 6 6 SER A 128 ASN A 137 1 10 HELIX 7 7 ASN A 152 ALA A 162 1 11 HELIX 8 8 PHE A 170 ARG A 177 1 8 HELIX 9 9 PHE A 179 LEU A 182 1 4 HELIX 10 10 PRO A 193 ASN A 198 5 6 HELIX 11 11 ASP A 217 TYR A 221 1 5 HELIX 12 12 ILE A 227 LEU A 238 1 12 HELIX 13 13 PRO A 240 ASP A 242 5 3 HELIX 14 14 LYS A 246 ALA A 255 1 10 HELIX 15 15 PRO A 280 GLY A 286 1 7 HELIX 16 16 ASN A 289 ALA A 292 1 4 HELIX 17 17 PRO A 330 LYS A 332 5 3 HELIX 18 18 ASN A 346 ASN A 358 1 13 HELIX 19 19 GLN B 6 GLN B 23 1 18 HELIX 20 20 GLY B 63 ALA B 79 5 17 HELIX 21 21 THR B 89 LYS B 91 5 3 HELIX 22 22 LYS B 99 TRP B 101 5 3 HELIX 23 23 LEU B 106 ALA B 110 1 5 HELIX 24 24 SER B 128 ASN B 137 1 10 HELIX 25 25 ASN B 152 SER B 166 1 15 HELIX 26 26 PHE B 170 ARG B 177 1 8 HELIX 27 27 PHE B 179 LEU B 182 1 4 HELIX 28 28 PRO B 193 ASN B 198 5 6 HELIX 29 29 ASP B 217 TYR B 221 1 5 HELIX 30 30 ILE B 227 LEU B 238 1 12 HELIX 31 31 PRO B 240 ASP B 242 5 3 HELIX 32 32 LYS B 246 ALA B 255 1 10 HELIX 33 33 PRO B 280 GLY B 286 1 7 HELIX 34 34 ASN B 289 ALA B 292 1 4 HELIX 35 35 PRO B 330 LYS B 332 5 3 HELIX 36 36 ASN B 346 ASN B 358 1 13 SHEET 1 A 6 LYS A 37 GLY A 44 0 SHEET 2 A 6 GLY A 27 TYR A 34 -1 N TYR A 34 O LYS A 37 SHEET 3 A 6 LEU A 334 ALA A 340 -1 N LEU A 339 O ALA A 29 SHEET 4 A 6 GLY A 323 ILE A 329 -1 N ILE A 329 O LEU A 334 SHEET 5 A 6 SER A 311 ALA A 318 -1 N GLY A 317 O SER A 324 SHEET 6 A 6 GLU A 272 ASP A 275 -1 N LEU A 274 O TRP A 312 SHEET 1 B 2 GLY A 202 ARG A 204 0 SHEET 2 B 2 LYS A 207 VAL A 209 -1 N VAL A 209 O GLY A 202 SHEET 1 C 2 TRP A 260 THR A 262 0 SHEET 2 C 2 MET A 265 GLN A 267 -1 N GLN A 267 O TRP A 260 SHEET 1 D 2 PHE A 60 GLY A 63 0 SHEET 2 D 2 VAL A 223 SER A 225 -1 N SER A 225 O PHE A 60 SHEET 1 E 8 LYS B 37 GLY B 44 0 SHEET 2 E 8 GLY B 27 TYR B 34 -1 N TYR B 34 O LYS B 37 SHEET 3 E 8 LEU B 334 ALA B 340 -1 N LEU B 339 O ALA B 29 SHEET 4 E 8 PHE B 322 ILE B 329 -1 N ILE B 329 O LEU B 334 SHEET 5 E 8 SER B 311 THR B 319 -1 N THR B 319 O PHE B 322 SHEET 6 E 8 GLU B 272 ASP B 275 -1 N LEU B 274 O TRP B 312 SHEET 7 E 8 MET B 265 GLN B 267 -1 N TYR B 266 O MET B 273 SHEET 8 E 8 TRP B 260 THR B 262 -1 N THR B 262 O MET B 265 SHEET 1 F 2 GLY B 202 ARG B 204 0 SHEET 2 F 2 LYS B 207 VAL B 209 -1 N VAL B 209 O GLY B 202 LINK OG SER A 64 B APB A 362 1555 1555 1.66 LINK OG SER B 64 B APB B 362 1555 1555 1.67 CISPEP 1 TRP A 276 PRO A 277 0 4.16 CISPEP 2 THR A 302 PRO A 303 0 -3.13 CISPEP 3 TRP B 276 PRO B 277 0 9.69 CISPEP 4 THR B 302 PRO B 303 0 -2.39 SITE 1 ACT 3 SER A 64 LYS A 67 TYR A 150 SITE 1 ACB 3 SER B 64 LYS B 67 TYR B 150 SITE 1 AC1 7 SER A 64 TYR A 150 THR A 316 GLY A 317 SITE 2 AC1 7 ALA A 318 ASN A 346 ARG A 349 SITE 1 AC2 7 SER B 64 TYR B 150 THR B 316 GLY B 317 SITE 2 AC2 7 ALA B 318 ASN B 346 ARG B 349 CRYST1 119.380 78.970 99.300 90.00 116.30 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008377 0.000000 0.004140 0.00000 SCALE2 0.000000 0.012663 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011233 0.00000 MTRIX1 1 -0.998240 0.058222 -0.011253 103.56140 1 MTRIX2 1 0.059293 0.977254 -0.203615 1.68154 1 MTRIX3 1 -0.000858 -0.203924 -0.978986 46.09845 1